Term
|
Definition
thiazide
DOC for uncomplicated HTN |
|
|
Term
|
Definition
thiazide
increases effectiveness of loop diuretic |
|
|
Term
|
Definition
thiazide
increases effectiveness of loop diuretic |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| carbonic anhydrase inhibitor |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
beta blocker
racemic mixture
d - beta blocker
l - vaso dilator |
|
|
Term
|
Definition
beta blocker
nonselective
used for migraines |
|
|
Term
|
Definition
ACE Inhibitor
used short term after MI (tid) |
|
|
Term
|
Definition
ACE Inhibitor
starting 10 mg PO QAM |
|
|
Term
|
Definition
ACE Inhibitor
starting 5 mg PO QAM |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
ACE Inhibitor
more lipophilic |
|
|
Term
|
Definition
ARB
starting dose 25 mg PO QAM
25, 50, 100 mg tabs |
|
|
Term
|
Definition
ARB
starting dose 80 mg PO QAM
40, 80, 160, and 320 mg tabs |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Calcium channel blocker
dihydropyridine
treat angina
starting 5 mg
2.5, 5, and 10 mg tabs |
|
|
Term
|
Definition
Calcium channel blocker
dihydropyridine
starting 5 mg
2.5, 5, and 10 mg tabs |
|
|
Term
|
Definition
Calcium channel blocker
dihydropyridine
starting 30 mg
30, 60, and 90 mg tabs |
|
|
Term
|
Definition
Calcium channel blocker
benzothiazipine
starting 180 mg
120, 180, 240, 360, 420 mg tabs |
|
|
Term
|
Definition
calcium channel blocker
diphenylalkylamine |
|
|
Term
|
Definition
alpha-1 blocker
1 mg PO QPM, increase every 3-5 days to target dose |
|
|
Term
|
Definition
|
|
Term
|
Definition
alpha-1 blocker
No BP effects |
|
|
Term
|
Definition
alpha-1 blocker
No BP effects |
|
|
Term
|
Definition
Central alpha-2 Agonist
0.1-0.2 m PO hypertensive crisis |
|
|
Term
|
Definition
Central alpha-2 Agonist
DOC for HTN in pregnancy |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Give the best drug for HTN:
Post MI |
|
Definition
|
|
Term
Give the best drug for HTN with:
High coronary disease risk |
|
Definition
|
|
Term
Give the best drug for HTN with:
Diabetes mellitus |
|
Definition
|
|
Term
Give the best drug for HTN with:
recurrent stroke prevention |
|
Definition
|
|
Term
Give the best drug for HTN with:
metabolic syndrome |
|
Definition
|
|
Term
|
Definition
| No ACE-I, ARBs, or renin inhibitors |
|
|
Term
| Post-menopausal women with HTN |
|
Definition
thiazide diuretic
inc. Ca2+ retention |
|
|
Term
| African Americans with HTN |
|
Definition
|
|
Term
|
Definition
| MI, heart failure, stroke, and kidney disease |
|
|
Term
Age 40-70
over 115/75 - 185/115
risk of CVD does what with each increment of 20 DP or 10 SP? |
|
Definition
| doubles with each increment |
|
|
Term
Anti-HTN therapy
% stroke reduction
% MI reduction
% heart failure reduction |
|
Definition
35-40% stroke reduction
20-25% MI reduction
> 50% HF reduction |
|
|
